Zobrazeno 1 - 10
of 68
pro vyhledávání: '"Muhammed Kashif"'
Autor:
Shuchi Gulati, McKenzie Crist, Muhammed Kashif Riaz, Vinita Takiar, Maria Lehn, Ilaina Monroe, Sarah Palackdharry, Nicky Kurtzweil, Roman Jandarov, Nusrat Harun, Trisha M. Wise-Draper
Publikováno v:
Clinical Cancer Research. 29:1906-1915
Purpose: The efficacy of cetuximab is poor in metastatic head and neck squamous cell carcinoma (HNSCC). Cetuximab initiates natural killer (NK) cell–mediated antibody-dependent cellular cytotoxicity, with resultant recruitment of immune cells and s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e11ca4d9b145a4397a99c9e932feecf6
https://doi.org/10.1158/1078-0432.ccr-22-3886
https://doi.org/10.1158/1078-0432.ccr-22-3886
Autor:
Jennifer L. Leddon, Shuchi Gulati, Sulsal Haque, Casey Allen, Sarah Palackdharry, Maria Mathews, Nicky Kurtzweil, Muhammed Kashif Riaz, Vinita Takiar, Misako Nagasaka, Yash Patil, Chad Zender, Alice Tang, Brian Cervenka, Julie McGrath, W. Michael Korn, Benjamin H. Hinrichs, Roman Jandarov, Nusrat Harun, Ammar Sukari, Trisha M. Wise-Draper
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 28, iss 16
Purpose: Locoregional relapse in patients with head and neck squamous cell carcinoma (HNSCC) is common, approaching 50% for some subsites despite multimodality therapy. Salvage surgery is the standard of care, but able to achieve durable control in o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5730e46f7826c241218e4050d6b050e
https://doi.org/10.1158/1078-0432.ccr-21-4554
https://doi.org/10.1158/1078-0432.ccr-21-4554
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Trisha M. Wise-Draper, Nusrat Harun, Roman Jandarov, Nicky Kurtzweil, Sarah Palackdharry, Ilaina Monroe, Maria Lehn, Vinita Takiar, Muhammed Kashif Riaz, McKenzie Crist, Shuchi Gulati
Supplementary Figure 5. Comparison of outcomes between patients that were PD-L1 positive vs. negative A) Progression-free survival and B) Overall survival comparison
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dd83873a53f1a42ff782129d01f3f7c
https://doi.org/10.1158/1078-0432.22820213.v1
https://doi.org/10.1158/1078-0432.22820213.v1
Autor:
Trisha M. Wise-Draper, Nusrat Harun, Roman Jandarov, Nicky Kurtzweil, Sarah Palackdharry, Ilaina Monroe, Maria Lehn, Vinita Takiar, Muhammed Kashif Riaz, McKenzie Crist, Shuchi Gulati
Purpose:The efficacy of cetuximab is poor in metastatic head and neck squamous cell carcinoma (HNSCC). Cetuximab initiates natural killer (NK) cell–mediated antibody-dependent cellular cytotoxicity, with resultant recruitment of immune cells and su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::68e81948eec90641746a5c3899a11cf5
https://doi.org/10.1158/1078-0432.c.6489320
https://doi.org/10.1158/1078-0432.c.6489320
Autor:
Trisha M. Wise-Draper, Nusrat Harun, Roman Jandarov, Nicky Kurtzweil, Sarah Palackdharry, Ilaina Monroe, Maria Lehn, Vinita Takiar, Muhammed Kashif Riaz, McKenzie Crist, Shuchi Gulati
All adverse events on trial
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34e0aa90cc85948dcc276e4386dfe832
https://doi.org/10.1158/1078-0432.22820198
https://doi.org/10.1158/1078-0432.22820198
Autor:
Trisha M. Wise-Draper, Nusrat Harun, Roman Jandarov, Nicky Kurtzweil, Sarah Palackdharry, Ilaina Monroe, Maria Lehn, Vinita Takiar, Muhammed Kashif Riaz, McKenzie Crist, Shuchi Gulati
Study protocol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a26c5e959e559bfdaa862cc7f9ce2adf
https://doi.org/10.1158/1078-0432.22551876.v1
https://doi.org/10.1158/1078-0432.22551876.v1
Autor:
Maura Gillison, Vinita Takiar, Nusrat Harun, J. Jack Lee, Mario Medvedovic, Roman Jandarov, Keith Casper, Michelle L. Mierzwa, Casey L. Allen, Maria Mathews, Nicky Kurtzweil, Diana Bell, Ann M. Gillenwater, Chad Zender, Jonathan Mark, Alice Tang, Muhammed Kashif Riaz, Yash Patil, John M. Kaczmar, Neal E. Dunlap, Matthew O. Old, Francis P. Worden, Benjamin H. Hinrichs, Sarah Palackdharry, Shuchi Gulati, Trisha M. Wise-Draper
Supplementary Figure from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::043fabc7d6ca2a922dd6f9f2c01ebdc8
https://doi.org/10.1158/1078-0432.22486398.v1
https://doi.org/10.1158/1078-0432.22486398.v1
Autor:
Maura Gillison, Vinita Takiar, Nusrat Harun, J. Jack Lee, Mario Medvedovic, Roman Jandarov, Keith Casper, Michelle L. Mierzwa, Casey L. Allen, Maria Mathews, Nicky Kurtzweil, Diana Bell, Ann M. Gillenwater, Chad Zender, Jonathan Mark, Alice Tang, Muhammed Kashif Riaz, Yash Patil, John M. Kaczmar, Neal E. Dunlap, Matthew O. Old, Francis P. Worden, Benjamin H. Hinrichs, Sarah Palackdharry, Shuchi Gulati, Trisha M. Wise-Draper
Supplementary Data from Phase II Clinical Trial of Neoadjuvant and Adjuvant Pembrolizumab in Resectable Local–Regionally Advanced Head and Neck Squamous Cell Carcinoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::42e63936c171b8dd8ce4ac3c4e149a45
https://doi.org/10.1158/1078-0432.22486401
https://doi.org/10.1158/1078-0432.22486401
Autor:
Maura Gillison, Vinita Takiar, Nusrat Harun, J. Jack Lee, Mario Medvedovic, Roman Jandarov, Keith Casper, Michelle L. Mierzwa, Casey L. Allen, Maria Mathews, Nicky Kurtzweil, Diana Bell, Ann M. Gillenwater, Chad Zender, Jonathan Mark, Alice Tang, Muhammed Kashif Riaz, Yash Patil, John M. Kaczmar, Neal E. Dunlap, Matthew O. Old, Francis P. Worden, Benjamin H. Hinrichs, Sarah Palackdharry, Shuchi Gulati, Trisha M. Wise-Draper
Purpose:Patients with resected, local–regionally advanced, head and neck squamous cell carcinoma (HNSCC) have a one-year disease-free survival (DFS) rate of 65%–69% despite adjuvant (chemo)radiotherapy. Neoadjuvant PD-1 immune-checkpoint blockade
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a1cdf4b8a3cbedd3c442a8c16f210c9
https://doi.org/10.1158/1078-0432.c.6532305
https://doi.org/10.1158/1078-0432.c.6532305